Abivax SA (ABVX) Earnings Date & Reports

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the bodyâ€™s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABVX is expected to report earnings to fall 14.29% to -68 cents per share on June 02

Q1'25

Est.

$-0.68

Q4'24

Beat

by $0.50

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.25

Q4'23

Beat

by $0.08

The last earnings report on March 24 showed earnings per share of -79 cents, beating the estimate of -128 cents. With 216.50K shares outstanding, the current market capitalization sits at 415.26M.

View a ticker or compare two or three

Compare

ABVX